GO:0160041 neuropeptide activity: Mechanism, Genes

Neuropeptides are small proteinaceous signaling molecules released by neurons that act as ligands for specific receptors, thereby modulating neuronal excitability, synaptic transmission, and broader physiological processes [1,5]. The Gene Ontology (GO) term GO:0160041, neuropeptide activity, captures this molecular function: the receptor ligand activity of any polypeptide expressed in, and secreted from, a neuron. This term is distinct from general neuropeptide hormone activity because it explicitly requires neuronal expression and secretion, reflecting the specialized role of these molecules in intercellular communication within the nervous system [1,6]. Understanding neuropeptide activity is essential for researchers studying neural circuit function, energy homeostasis, stress responses, and pain modulation, as these ligands often serve as key nodes linking neuronal activity to systemic physiology [1,5,8]. The importance of GO:0160041 extends beyond basic neurobiology. Neuropeptides such as orexin, neuropeptide Y (NPY), and osteocalcin have been shown to influence behaviors ranging from voluntary exercise to stress resilience and vascular tone [1,6,8]. For example, orexin neurons mediate temptation-resistant voluntary exercise, highlighting how a single neuropeptide can drive complex behavioral outputs. Similarly, NPY-mediated vasoconstriction is subject to functional sympatholysis, illustrating the interplay between neuropeptide signaling and cardiovascular control. These examples underscore why precise annotation of neuropeptide activity is critical for interpreting functional genomics data and for developing targeted therapeutic strategies [5,8]. In the post-genomic era, linking GO:0160041 to specific genes and experimental models is vital for translational research. Knockout and knock-in animal models, coupled with CRISPR screening, allow researchers to test causality between neuropeptide ligands and disease phenotypes [1,5]. This article synthesizes current knowledge on the molecular mechanism, key genes, regulatory context, and research methods relevant to neuropeptide activity, providing a resource for scientists aiming to study this function in health and disease [2,3,4].

According to the Gene Ontology, GO:0160041 (neuropeptide activity) is defined as the receptor ligand activity of any polypeptide expressed in, and secreted from, a neuron. In other words, it describes the function of a neuronal protein that is released from a neuron and binds to a receptor on a target cell to elicit a response. This definition emphasizes two key criteria: the polypeptide must be expressed in a neuron, and it must be secreted to act as a ligand. It does not cover neuropeptides that are not secreted or those expressed predominantly in non-neuronal cells. The term is a molecular function, meaning it describes what a gene product does at the molecular level, rather than a biological process or cellular component.

Neuropeptide activity is a fundamental molecular function that bridges neuronal activity and systemic physiology. Because neuropeptides are secreted from neurons and act as receptor ligands, they serve as key communication molecules in circuits controlling arousal, feeding, stress, pain, and cardiovascular tone [1,5,6]. Dysregulation of this activity is associated with a wide range of disorders, including chronic pain, anxiety, obesity, and hypertension [5,6,8]. Moreover, neuropeptides are attractive drug targets because their release and receptor interactions can be modulated pharmacologically. Understanding GO:0160041 at the molecular level therefore has direct implications for neuroscience, endocrinology, and therapeutic development [1,8].

The following genes encode neuropeptides or related proteins that exhibit neuropeptide activity (GO:0160041) or modulate its function, based on published literature.

Neuropeptide activity is regulated at multiple levels, including gene transcription, post-translational processing, vesicular packaging, and release probability. Neuronal activity and physiological states such as exercise can modulate the expression and secretion of neuropeptides [1,2,3,4]. For example, exercise intensity affects circulating cortisol levels, which may in turn influence neuropeptide gene expression. Skeletal muscle Rac1 mediates exercise training adaptations, suggesting systemic crosstalk that could impact neuropeptide signaling. Additionally, receptor desensitization and extracellular peptidase activity provide feedback regulation [5,6]. The precise regulatory mechanisms vary by neuropeptide and cell type, but they collectively ensure that neuropeptide signals are tightly coupled to physiological demand.

Dysregulated neuropeptide signaling is a hallmark of chronic pain states. In a mouse tibia fracture model, exercise reversed nociceptive sensitization, upregulated neuropeptide signaling, inflammatory changes, anxiety, and memory impairment. This suggests that neuropeptides such as substance P and CGRP contribute to pain chronification and that modulating their activity could be therapeutic. Anxiety and memory deficits in this model were also linked to neuropeptide dysregulation, highlighting the broad impact of neuropeptide activity on brain function.

NPY is a potent vasoconstrictor, and its activity is subject to functional sympatholysis in humans. Impairment of this mechanism could contribute to hypertension or exercise intolerance. Orexin neurons mediate voluntary exercise, and their dysfunction is associated with narcolepsy and metabolic dysregulation. Osteocalcin, acting as a stress-responsive neuropeptide, links bone metabolism to stress responses, with potential implications for osteoporosis and stress-related disorders.

Exercise induces systemic changes, including secretion of cathepsin B from muscle, which is associated with memory function. Cortisol levels vary with exercise intensity, potentially affecting neuropeptide activity. Rac1 in skeletal muscle mediates exercise adaptations, suggesting that neuropeptide signaling may be part of a broader systemic response to exercise. These findings position neuropeptide activity as a mediator of exercise benefits on brain health [2,4].

CRISPR-Cas9 knockout of neuropeptide genes in mice or cell lines allows researchers to test loss-of-function phenotypes. For example, Hcrt knockout mice exhibit altered exercise behavior. Conditional knockout using Cre-lox systems enables tissue-specific deletion, which is valuable for distinguishing neuronal versus peripheral roles [1,5].

RNA sequencing and mass spectrometry can quantify neuropeptide precursor expression and mature peptide levels in tissues or biofluids. These methods have been used to identify exercise-induced changes in cathepsin B and other circulating factors [2,4]. Proteomic profiling of cerebrospinal fluid or plasma can reveal neuropeptide signatures associated with disease states.

Fluorescent reporters and calcium imaging can track neuropeptide release and neuronal activity in real time. Fiber photometry of orexin neurons has been used to link neural activity to voluntary exercise. Immunohistochemistry can localize neuropeptides in brain sections.

Receptor binding assays and pharmacological agonists/antagonists help define neuropeptide-receptor interactions. For instance, NPY-mediated vasoconstriction can be assessed using infusion studies in humans. Such assays are critical for validating the receptor ligand activity defined by GO:0160041.

Researchers studying neuropeptide activity-related genes often need to determine whether a candidate gene is causally involved in a specific physiological or disease process. This requires precise genetic tools to manipulate gene function in relevant cell types and model organisms. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such investigations, from knockout to knock-in and overexpression models, as well as library screening and bioinformatics support.

GO:0160041 (neuropeptide activity) defines a critical molecular function at the interface of neuronal secretion and receptor-mediated signaling. The term encompasses diverse peptides such as orexin, NPY, and osteocalcin, which regulate exercise, cardiovascular tone, stress, and pain [1,5,6,8]. Understanding the genes, regulatory mechanisms, and disease associations of neuropeptide activity is essential for both basic neuroscience and therapeutic development. CRISPR-based models and advanced screening methods provide powerful tools to dissect these pathways, and EDITGENE offers comprehensive services to support such research.